Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Kiniksa Pharmaceuticals Ltd
Cash from Investing Activities
Kiniksa Pharmaceuticals Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
Cash from Investing Activities
-$29.6m
|
CAGR 3-Years
24%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
See Also
What is Kiniksa Pharmaceuticals Ltd's Cash from Investing Activities?
Cash from Investing Activities
-29.6m
USD
Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Cash from Investing Activities amounts to -29.6m USD.
What is Kiniksa Pharmaceuticals Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
35%
Over the last year, the Cash from Investing Activities growth was -27%. The average annual Cash from Investing Activities growth rates for Kiniksa Pharmaceuticals Ltd have been 24% over the past three years , 35% over the past five years .